Sree Gongala, Jose A Garcia, Nisha Korakavi, Nirav Patil, Hamed Akbari, Andrew Sloan, Jill S Barnholtz-Sloan, Jessie Sun, Brent Griffith, Laila M Poisson, Thomas C Booth, Rajan Jain, Suyash Mohan, MacLean P Nasralla, Spyridon Bakas, Charit Tippareddy, Josep Puig, Joshua D Palmer, Wenyin Shi, Rivka R Colen, Aristeidis Sotiras, Sung Soo Ahn, Yae Won Park, Christos Davatzikos, Chaitra Badve
BACKGROUND: Understanding sex-based differences in glioblastoma patients is necessary for accurate personalized treatment planning to improve patient outcomes. PURPOSE: To investigate sex-specific differences in molecular, clinical and radiological tumor parameters, as well as survival outcomes in glioblastoma, isocitrate dehydrogenase-1 wildtype (IDH1-WT), grade 4 patients. METHODS: Retrospective data of 1832 glioblastoma, IDH1-WT patients with comprehensive information on tumor parameters was acquired from the Radiomics Signatures for Precision Oncology in Glioblastoma (ReSPOND) consortium...
April 29, 2024: AJNR. American Journal of Neuroradiology